Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

GEN Insider Trading

GEN | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at GEN provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2018-09-07 21:23 2018-09-05 Reis David A Director SELL $1.64 900 $1,473 193,751 -0.5%
2018-09-05 23:22 2018-08-31 Reis David A Director SELL $1.74 47,755 $82,922 193,810 -19.8%
2018-08-31 18:09 2018-08-29 Reis David A Director SELL $1.74 44,975 $78,400 196,914 -18.6%
2018-08-29 22:56 2018-08-27 Reis David A Director SELL $1.72 64,064 $110,126 199,837 -24.3%
2018-08-28 00:32 2018-08-23 Reis David A Director SELL $1.70 71,070 $120,620 204,001 -25.8%
2018-08-27 22:48 2018-08-14 Reis David A Director SELL $1.63 68 $111 97,029 -0.1%
2018-08-15 02:37 2018-08-10 Reis David A Director SELL $1.65 47,365 $78,043 208,620 -18.5%
2018-08-11 01:09 2018-08-08 Reis David A Director SELL $1.69 101,404 $171,393 211,698 -32.4%
2018-06-13 22:39 2018-06-12 Bach Paul David Officer - COO SELL $2.28 5,735 $13,083 751,305 -0.8%
2018-06-13 23:05 2018-06-12 Reifsnyder JoAnne Susan Officer - EVP and Chief Nursing Officer SELL $2.28 4,877 $11,125 484,294 -1.0%
2018-06-13 23:18 2018-06-12 Sherman Michael Scott Officer - SVP and General Counsel SELL $2.28 3,516 $8,021 604,061 -0.6%
2018-06-13 23:33 2018-06-12 Young Stephen Scott Officer - SVP and Corporate Controller SELL $2.28 3,665 $8,361 299,294 -1.2%
2018-06-13 22:52 2018-06-12 DiVittorio Thomas Officer - SVP and CFO SELL $2.28 5,899 $13,457 790,775 -0.7%
2018-06-07 18:06 2018-06-05 Bach Paul David Officer - COO SELL $2.19 10,131 $22,200 571,140 -1.7%
2018-06-07 20:33 2018-06-05 Reifsnyder JoAnne Susan Officer - EVP and Chief Nursing Officer SELL $2.19 7,488 $16,408 356,371 -2.1%
2018-06-07 20:51 2018-06-05 Sherman Michael Scott Officer - SVP and General Counsel SELL $2.19 5,797 $12,703 488,777 -1.2%
2018-06-07 21:08 2018-06-05 Young Stephen Scott Officer - SVP and Corporate Controller SELL $2.19 4,857 $10,643 210,859 -2.3%
2018-06-07 18:28 2018-06-05 DiVittorio Thomas Officer - SVP and CFO SELL $2.19 9,404 $20,607 610,774 -1.5%
2017-06-15 22:08 2017-06-14 Bach Paul David Officer - COO SELL $1.73 6,100 $10,551 603,271 -1.0%
2017-06-15 23:06 2017-06-14 Reifsnyder JoAnne Susan Officer - EVP and Chief Nursing Officer SELL $1.73 5,269 $9,113 382,859 -1.4%
2017-06-15 23:30 2017-06-14 Sherman Michael Scott Officer - SVP and General Counsel SELL $1.73 3,903 $6,751 510,574 -0.8%
2017-06-15 23:18 2017-06-14 Young Stephen Scott Officer - VP and Corporate Controller SELL $1.73 3,799 $6,571 229,216 -1.6%
2017-06-15 22:49 2017-06-14 Hirschfeld Daniel Allen Officer - COO Int'l. Oper. & Rehab Svcs. SELL $1.73 7,245 $12,531 623,821 -1.1%
2017-06-15 22:33 2017-06-14 DiVittorio Thomas Officer - SVP and CFO SELL $1.73 6,341 $10,967 645,678 -1.0%
2017-06-09 22:13 2017-06-07 Reifsnyder JoAnne Susan Officer - EVP and Chief Nursing Officer SELL $1.61 2,383 $3,847 388,128 -0.6%
2017-06-09 22:40 2017-06-07 Sherman Michael Scott Officer - SVP and General Counsel SELL $1.61 1,824 $2,944 514,477 -0.4%
2017-06-09 22:56 2017-06-07 Young Stephen Scott Officer - VP and Corporate Controller SELL $1.61 1,541 $2,487 233,015 -0.7%
2017-06-09 21:48 2017-06-07 Hirschfeld Daniel Allen Officer - COO Int'l. Oper. & Rehab Svcs. SELL $1.61 2,895 $4,673 631,066 -0.5%
2017-06-09 21:22 2017-06-07 Bach Paul David Officer - COO SELL $1.61 2,769 $4,470 518,947 -0.5%
2017-06-09 21:36 2017-06-07 DiVittorio Thomas Officer - SVP and CFO SELL $1.61 2,900 $4,681 652,019 -0.4%
2016-08-30 22:22 2016-08-29 Young Stephen Scott Officer - VP and Corporate Controller SELL $2.38 10,000 $23,840 160,874 -5.9%
2016-06-09 21:30 2016-06-08 Sherman Michael Scott Officer - SVP and General Counsel SELL $1.72 1,919 $3,305 421,301 -0.5%
2016-06-09 20:54 2016-06-08 Reifsnyder JoAnne Susan Officer - EVP and Chief Nursing Officer SELL $1.72 2,207 $3,802 284,261 -0.8%
2016-06-09 18:42 2016-06-08 Hirschfeld Daniel Allen Officer - COO Int'l. Oper. & Rehab Svcs. SELL $1.72 3,009 $5,183 485,211 -0.6%
2016-06-09 16:59 2016-06-08 Young Stephen Scott Officer - VP and Corporate Controller SELL $1.72 1,621 $2,792 170,874 -0.9%
2016-06-09 17:26 2016-06-08 DiVittorio Thomas Officer - SVP and CFO SELL $1.72 3,051 $5,255 506,169 -0.6%
2016-06-09 21:15 2016-06-08 REITZ ROBERT A Officer - EVP and COO SELL $1.72 3,892 $6,704 511,328 -0.8%
2016-06-09 18:04 2016-06-08 HAGER GEORGE V JR Director, Officer, 10% owner - CEO SELL $1.72 6,031 $10,388 1,536,749 -0.4%
2015-11-24 03:00 2015-11-19 Whitman Arnold M Director, 10% owner BUY $4.54 43,200 $196,214 6,937,750 +0.6%
2015-11-13 23:16 2015-11-11 DiVittorio Thomas Officer - SVP & CFO BUY $4.34 20,000 $86,860 387,220 +5.4%
2015-11-13 20:01 2015-11-12 MCKEON JAMES V Director BUY $4.15 10,000 $41,500 29,802 +50.5%
2011-09-01 17:21 2011-08-31 Murray Robert C Director BUY $3.06 15,000 $45,900 15,000 +100.0%
2011-05-13 23:24 2011-05-12 Gaudette Robert J Officer - SVP, Chief Commercial Officer SELL $3.70 30,000 $111,000 41,408 -42.0%
2011-05-13 23:12 2011-05-12 PEREZ LAREE E Director SELL $3.72 25,612 $95,282 55,607 -31.5%
2009-03-17 00:16 2009-02-25 BARRANTES CHARLES E Officer - Chief Financial Officer BUY $0.99 2,000 $1,977 19,000 +11.8%
2008-12-03 23:55 2008-12-03 BARRANTES CHARLES E Officer - Chief Financial Officer BUY $1.85 2,000 $3,700 15,000 +15.4%
SHOW ENTRIES

How to Interpret $GEN Trades

Not every insider transaction in GEN is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $GEN shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for GEN

Insider activity data for GEN is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $GEN, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.